Matches in Wikidata for { <http://www.wikidata.org/entity/Q64122619> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q64122619 description "clinical trial" @default.
- Q64122619 description "ensayu clínicu" @default.
- Q64122619 description "klinisch onderzoek" @default.
- Q64122619 description "клінічне випробування" @default.
- Q64122619 name "Effects of Apalutamide Plus LHRH Agonist or Apalutamide Plus Abiraterone Acetate Plus LHRH Agonist for Six Months for Prostate Cancer Patients at High Risk for Recurrence" @default.
- Q64122619 type Item @default.
- Q64122619 label "Effects of Apalutamide Plus LHRH Agonist or Apalutamide Plus Abiraterone Acetate Plus LHRH Agonist for Six Months for Prostate Cancer Patients at High Risk for Recurrence" @default.
- Q64122619 prefLabel "Effects of Apalutamide Plus LHRH Agonist or Apalutamide Plus Abiraterone Acetate Plus LHRH Agonist for Six Months for Prostate Cancer Patients at High Risk for Recurrence" @default.
- Q64122619 P1132 Q64122619-A82F64D3-5BE1-4951-942B-2F0688446A57 @default.
- Q64122619 P1476 Q64122619-634AE416-8882-4E01-BFFA-F348FA38969D @default.
- Q64122619 P17 Q64122619-6519BDF0-1AB7-4F8E-8B25-58D57F31C567 @default.
- Q64122619 P2899 Q64122619-BCB6F929-D6A6-4D01-9FA1-A859DDA8CACB @default.
- Q64122619 P3098 Q64122619-BF348B0C-D7DE-4782-8CB0-75C61E338FD2 @default.
- Q64122619 P31 Q64122619-5434F8C1-4FAC-473F-BC6E-CB29B3FCE1B2 @default.
- Q64122619 P4844 Q64122619-028DC64C-7808-46A6-A4BC-F6BC2731EF8C @default.
- Q64122619 P4844 Q64122619-7D3DC24B-A302-44CD-8F18-6413ED6A1CF7 @default.
- Q64122619 P580 Q64122619-BE6183BB-A106-4A55-A676-C797808F820C @default.
- Q64122619 P582 Q64122619-444343C6-8316-412C-AB12-191A6CB22002 @default.
- Q64122619 P6099 Q64122619-8E7B8168-D709-4E92-9FE7-541C4B0F1CC0 @default.
- Q64122619 P8363 Q64122619-481F2CAC-E0AA-420F-83EF-04721E3AA7AD @default.
- Q64122619 P1132 "+66" @default.
- Q64122619 P1476 "A Pre-Operative Study to Assess the Effects of Apalutamide Plus LHRH Agonist or Apalutamide Plus Abiraterone Acetate Plus LHRH Agonist for Six Months for Prostate Cancer Patients at High Risk for Recurrence" @default.
- Q64122619 P17 Q30 @default.
- Q64122619 P2899 "+18" @default.
- Q64122619 P3098 "NCT03279250" @default.
- Q64122619 P31 Q30612 @default.
- Q64122619 P4844 Q424972 @default.
- Q64122619 P4844 Q907160 @default.
- Q64122619 P580 "2017-10-13T00:00:00Z" @default.
- Q64122619 P582 "2022-02-28T00:00:00Z" @default.
- Q64122619 P6099 Q42824440 @default.
- Q64122619 P8363 Q78089383 @default.